Bradley Stein
@bradleydstein.bsky.social
1.2K followers 860 following 130 posts
Child psychiatrist/ health services/policy researcher at RAND, studying improving access, treatment, and outcomes for individuals with mental health and substance use disorders. Often found at youth soccer games and finding recipes to try in my smoker
Posts Media Videos Starter Packs
bradleydstein.bsky.social
Really important research about a school mental health intervention. Studies without significant findings often have a hard time getting published, but its just as important to know what interventions don't seem to have a significant benefit as knowing what interventions do.
lucyfoulkes.bsky.social
New paper from my group, led by Carolina Guzman Holst

This is a secondary analysis of data from the high-quality MYRIAD trial, a universal school-based mindfulness intervention

Summary below (🧵)

acamh.onlinelibrary.wiley.com/doi/10.1002/...
Adolescents' trajectories of mental health in the MYRIAD trial Abstract
Background
This study explored adolescent's mental health trajectories over the course of a school-based mindfulness-based intervention trial (MYRIAD). It examined whether intervention condition (mindfulness vs. teaching-as-usual), individual-level and contextual-level factors were associated with different trajectories.

Methods
This pre-registered study used data from 11- to 14-year-olds who participated in the MYRIAD trial. We used growth mixture models to examine distinct trajectories in risk for depression, social-emotional-behavioural functioning, and wellbeing (co-primary outcomes), and anxiety (secondary outcome), across pre-intervention, post-intervention and 12-month follow up (ns = 7198–7727). We then used multinomial and binomial logistic regression models to examine factors associated with individual trajectory membership. Results
Distinct trajectories emerged for each outcome: A five-trajectory model best explained the changes in risk for depression, whilst four-trajectory models best explained changes in social-emotional-behavioural functioning, wellbeing, and anxiety. While 69%–80% of adolescents followed stable low-problem trajectories for each outcome, 11%–23% experienced stable high-problem trajectories, 2%–16% experienced increasing-problem trajectories and 1%–5% experienced decreasing-problem trajectories. Receiving the mindfulness intervention was not associated with any mental health trajectory in models adjusted for confounders. Several individual-level factors, including executive functioning difficulties and risk of mental health problems at baseline, and school-level factors, such as school climate, predicted adolescents' classification into different trajectories, but they did not vary according to intervention group.

Conclusions
Individual differences in mental health trajectories emerged over the course of a 1-year mindfulness-based intervention, with most adolescents experiencing low-stable problem trajectories for each outcome. However, the intervention itself had no impact on individual trajectory membership, mirroring null results found in the main trial. Our findings suggest that universal interventions may not be sensitive enough to address the diverse needs of all students, however, tailoring interventions to address a range of different individual and contextual factors might maximise their impact.
bradleydstein.bsky.social
Pediatricians, child psychiatrists and educators need to work together to help families find solutions—like pharmacy navigation and behavioral supports—so kids don’t fall behind during medication shortages
bradleydstein.bsky.social
These differences mean the shortage could deepen existing gaps in academic achievement and behavioral health for children already facing challenges and barriers to care
bradleydstein.bsky.social
Teachers in these schools were significantly more likely to report students having to stop their medication—over 77% in majority-minority schools and 76% in schools with mostly low-income students.
bradleydstein.bsky.social
New research alert: The nationwide stimulant shortage didn’t affect all schools equally. Our new national study in JAACAP found much higher rates of ADHD medication interruption in schools where most students are from racial/ethnic minorities or low-income backgrounds.
bradleydstein.bsky.social
These treatment settings all matter for recovery, meaning broader Medicaid access offered more pathways for people with SUD to get help when needed most, critical when the overdose crisis was intensifying
bradleydstein.bsky.social
Even 6+ years later, treatment rates remained higher than pre-expansion, showing sustained improvements—not just a one-time bump.
bradleydstein.bsky.social
Treatment episodes for SUD surged across the board in the first 2-3 years after expansion: overall rates up 39–40% after 2–5 years, with strong gains across the board, in residential, intensive outpatient, and non-intensive outpatient care.
bradleydstein.bsky.social
New research led by @jcmecon.bsky.social of @georgemasonu.bsky.social in @healthaffairs.bsky.social finds Medicaid expansion has yielded lasting gains in access to specialty substance use disorder (SUD) treatment—benefiting thousands experiencing drug or alcohol problems.
bradleydstein.bsky.social
Thanks to the NIMH for funding this work and shout-out to all the school leaders who responded to the @rand.org American School Leader Panel!
bradleydstein.bsky.social
Policymakers and school boards: are you considering neighborhood context when crafting phone policies? Open dialogue with parents, teachers, and students is key to making effective rules
bradleydstein.bsky.social
These differences raise important questions on equity and the impacts for different student populations— teens using phones more freely at school could see impacts on learning and mental health. Middle and high school principals face tough choices balancing safety, independence, and distractions.
bradleydstein.bsky.social
And most elementary schools stick to strict bans: over 81% only allow phones on campus if students keep them put away all day. By high school, policies get much looser—many let students use phones outside class or at teacher discretion.
bradleydstein.bsky.social
Our national analysis found schools in higher-income communities are more likely to allow phones than those in high-poverty neighborhoods.
bradleydstein.bsky.social
New Research Alert: Did you know nearly all U.S. public schools restrict student cell phone use—but the types of bans are very different depending on the school? Our recent paper, led by led by my @rand.org colleague Jon Cantor, just published in @jamahealthforum.com examines this issue
bradleydstein.bsky.social
Such an important topic. Great to see @parcka.bsky.social diving into this with my @rand.org colleague Liz!
parcka.bsky.social
Talking with youth about substance use isn’t easy. Dr. Elizabeth D’Amico shares how Motivational Interviewing #MI can help build trust. 🩷🎧 Listen to the newest episode of Let’s Talk About Drugs in the Intermountain West #LTAD now!
bradleydstein.bsky.social
Want all the numbers? Check out the NIDA and Foundation for Opioid Response Efforts supported study here:

journals.lww.com/journaladdic...
bradleydstein.bsky.social
Bottom line: Medicaid unwinding wasn’t just a paperwork issue- it disrupted effective treatment of opioid use disorder for thousands. Policymakers must find ways to protect coverage and care continuity as insurance rules evolve.
bradleydstein.bsky.social
Did other insurance types like commercial insurance and Medicare, or paying out-of-pocket pocket fill the gap? Turns out, they didn’t: overall, more people ended up going without effective treatment.
bradleydstein.bsky.social
In states with the greatest Medicaid disenrollment, the changes were greatest: ending episodes rose +5.5%, and new starts fell nearly -4% after unwinding.
bradleydstein.bsky.social
Our national study led by @rand.org colleague Rachel Landis in the American Society of Addiction Medicine’s Journal of Addiction Medicine found that after unwinding, more Medicaid buprenorphine treatment episodes ended (+3%), and fewer Medicaid treatment episodes started (-2.6%).